Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
De Beers is the world's leading diamond company, with expertise in the exploration, mining, grading, marketing, and retail of diamonds. While primarily a mining and luxury goods entity, its subsidiary Element Six is a leader in synthetic diamond technology, which has niche applications in the life sciences, including high-precision surgical tools and diamond-based quantum sensing for medical diagnostics. The company is not a biotechnology or pharmaceutical developer and does not maintain a drug pipeline. For a biotech analyst, De Beers is relevant only through its materials science contributions to medical devices and diagnostic hardware.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on De Beers.